How Foreign Is Too Foreign?
Sort-of Foreigner Could Be Cancer Diagnostic, Target
By Anette Breindl
Wednesday, April 20, 2011
One of the basic ways to classify antibodies is whether they are to self or nonself. But researchers from the University of California, San Diego and start-up Sialix Inc. have identified an antibody that is arguably both and that might be useful as a cancer diagnostic or therapeutic.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.